Abivax (ABVX) Return on Invested Capital (2025 - 2026)

Abivax (ABVX) posted quarterly Return on Invested Capital of 0.01% for Q1 2026, down 41.22% quarter-over-quarter from 0.01% in Q4 2025.

Abivax (ABVX) Return on Invested Capital (2025 - 2026) Analysis & Trends

Abivax's Return on Invested Capital history runs 2 years deep, the most recent figure standing at 0.01% for Q1 2026.

In Q1 2026, Return on Invested Capital changed N/A year-over-year to 0.01%; the TTM figure through Mar 2026 stood at 0.01% (changed N/A YoY), while the FY2025 annual figure was 0.04%, changed N/A from the prior year.
Return on Invested Capital for Q1 2026 stood at 0.01%, down from 0.01% in the prior quarter.
The five-year high for Return on Invested Capital was 0.01% in Q4 2025, with the low at 0.01% in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROIC (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	0.04%
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	0.00%
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-0.05%
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-0.35%
10	Abivax	9.39 Bn	9.39 Bn	-	-0.01%

Download Data

Date	Value
Mar 31, 2026	-0.01%
Dec 31, 2025	-0.01%